Latest & greatest articles for calcium

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on calcium or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on calcium and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for calcium

141. WITHDRAWN: Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults.

WITHDRAWN: Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults. BACKGROUND: Patients with paroxysmal supraventricular tachycardia frequently present to the Emergency Department. Where vagal manoeuvres fail, the two most commonly used drugs are adenosine and calcium channel antagonists. Both are known to be effective but both have a significant side-effect profile. OBJECTIVES: To examine the relative effects of adenosine (...) and calcium channel antagonists and, if possible, to determine which is most appropriate for the management of supraventricular tachycardia. SEARCH METHODS: Studies were identified from The Cochrane Central Register of Controlled Trials (CENTRAL) on The Cochrane Library, Issue 2, 2010, MEDLINE (1966 to May Week 1 2010) and EMBASE (1980 to 2010 week 19). The searches were originally run in June 2006 and updated and re-run in May 2010. Bibliographies of identified studies were also examined. No language

Cochrane2012

142. Cost-effectiveness of aspirin, celecoxib, and calcium chemoprevention for colorectal cancer

Cost-effectiveness of aspirin, celecoxib, and calcium chemoprevention for colorectal cancer Cost-effectiveness of aspirin, celecoxib, and calcium chemoprevention for colorectal cancer Cost-effectiveness of aspirin, celecoxib, and calcium chemoprevention for colorectal cancer Squires H, Tappenden P, Cooper K, Carroll C, Logan R, Hind D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study assessed the cost-effectiveness of aspirin, celecoxib, or calcium for the prevention of colorectal cancer, with a screening programme, for the general population or those who had undergone colorectal polypectomy. Calcium chemoprevention was likely to be cost-effective after polypectomy, but the evidence was weak. Aspirin could be cost

NHS Economic Evaluation Database.2012

143. Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate

Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate; a meta-analysis of randomized trials Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate; a meta-analysis of randomized trials Makani H, Bangalore S, Romero J, Htyte N, Berrios RS, Makwana H, Messerli FH CRD summary The review concluded that incidence of peripheral oedema and (...) patient withdrawal increased with duration of calcium channel blocker therapy up to six months. Rates were lower with both non-dihydropyridines and lipophilic dihydropyridines. Given lack of clarity on quality and potential for bias in the review process, the authors' conclusions should be considered tentative. Authors' objectives To evaluate the incidence and withdrawal rate of peripheral oedema with calcium channel blockers (CCBs), effect of treatment duration on oedema incidence and compare

DARE.2012

144. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. preventive services task force

Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. preventive services task force Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. preventive services task force Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. preventive services task force Chung M, Lee J (...) , Terasawa T, Lau J, Trikalinos TA CRD summary The authors concluded that combined vitamin D and calcium supplementation can reduce fracture risk in adults. There was insufficient evidence to draw conclusions on cancer prevention. The authors' conclusion reflects the evidence presented and seems largely reliable. Authors' objectives To update on the effects of vitamin D supplementation (with or without calcium supplementation) on cancer and fracture outcomes in adults. The review also included

DARE.2012

145. Study of the effect of calcium supplementation during pregnancy on the risk of preterm birth or low birthweight infants is inconclusive

Study of the effect of calcium supplementation during pregnancy on the risk of preterm birth or low birthweight infants is inconclusive Study of the effect of calcium supplementation during pregnancy on the risk of preterm birth or low birthweight infants is inconclusive | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Study of the effect of calcium supplementation during pregnancy on the risk of preterm birth or low birthweight infants is inconclusive Article Text Therapeutics Study of the effect of calcium supplementation during pregnancy

Evidence-Based Medicine (Requires free registration)2012

146. Combined vitamin D and calcium supplementation may reduce fracture risk in institutionalised older people but has uncertain role in cancer prevention

Combined vitamin D and calcium supplementation may reduce fracture risk in institutionalised older people but has uncertain role in cancer prevention Combined vitamin D and calcium supplementation may reduce fracture risk in institutionalised older people but has uncertain role in cancer prevention | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Combined vitamin D and calcium supplementation may reduce fracture risk in institutionalised older people but has uncertain role in cancer prevention Article Text Therapeutics Combined vitamin D and calcium

Evidence-Based Medicine (Requires free registration)2012

147. Randomised controlled trial: Calcium supplements may increase the risk of cardiovascular events in postmenopausal women

Randomised controlled trial: Calcium supplements may increase the risk of cardiovascular events in postmenopausal women Calcium supplements may increase the risk of cardiovascular events in postmenopausal women | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Calcium supplements may increase the risk of cardiovascular events in postmenopausal women Article Text Therapeutics Randomised controlled trial Calcium supplements may increase the risk of cardiovascular events in postmenopausal women Barbara J Boucher Statistics from Altmetric.com No Altmetric data

Evidence-Based Medicine (Requires free registration)2012

148. Cohart Study: Various vitamin and mineral supplements are observed to increase mortality risk in older women, with the exception of calcium, which decreases risk

Cohart Study: Various vitamin and mineral supplements are observed to increase mortality risk in older women, with the exception of calcium, which decreases risk Various vitamin and mineral supplements are observed to increase mortality risk in older women, with the exception of calcium, which decreases risk | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Various vitamin and mineral supplements are observed to increase mortality risk in older women, with the exception of calcium, which decreases risk Article

Evidence-Based Nursing (Requires free registration)2012

149. Comparison of percutaneous screw fixation and calcium sulfate cement grafting versus open treatment of displaced intra-articular calcaneal fractures

Comparison of percutaneous screw fixation and calcium sulfate cement grafting versus open treatment of displaced intra-articular calcaneal fractures 22232815 2012 01 09 2012 08 14 2017 02 14 1071-1007 32 10 2011 Oct Foot & ankle international Foot Ankle Int Comparison of percutaneous screw fixation and calcium sulfate cement grafting versus open treatment of displaced intra-articular calcaneal fractures. 979-85 The conventional treatment for displaced intraarticular fractures of the calcaneus (...) (DIACF), with open reduction and internal plate fixation (ORIF), carries the risk of wound infection and delayed recovery. Alternatively percutaneous fixation techniques offer the possibility of equivalent outcomes in with a reduction in soft tissue complications. The goal of the present study was to evaluate the outcome of percutaneous reduction (PR), screw fixation, and calcium sulphate cement (CSC) grafting in the treatment of DIACF. Ninety patients were randomly assigned to PR and CSC grafting

EvidenceUpdates2012

150. Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema

Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Makani H, Bangalore S, Romero J, Wever-Pinzon O, Messerli FH CRD summary This review concluded that in patients with hypertension, calcium channel blockers with renin-angiotensin system blockers reduced (...) the risk of peripheral oedema compared with monotherapy. The authors' conclusions appear to reflect the evidence, but lack of reporting on details of individual trials mean these conclusions should be interpreted with caution as the results may not be generalisable. Authors' objectives To evaluate the risk of peripheral oedema in patients who received calcium channel blocker/rennin-angiotensin system combination therapy compared to calcium channel blocker monotherapy and to evaluate the difference

DARE.2011

151. To supplement or not to supplement: a cost-utility analysis of calcium and vitamin D repletion in patients after thyroidectomy

To supplement or not to supplement: a cost-utility analysis of calcium and vitamin D repletion in patients after thyroidectomy To supplement or not to supplement: a cost-utility analysis of calcium and vitamin D repletion in patients after thyroidectomy To supplement or not to supplement: a cost-utility analysis of calcium and vitamin D repletion in patients after thyroidectomy Wang TS, Cheung K, Roman SA, Sosa JA Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study assessed the incremental cost-utility of routine supplementation with calcium and vitamin D, compared with selective supplementation, for patients after total or completion of thyroidectomy. Routine supplementation was less expensive and slightly increased patient

NHS Economic Evaluation Database.2011

152. Calcium channel blockers for neuroleptic-induced tardive dyskinesia.

Calcium channel blockers for neuroleptic-induced tardive dyskinesia. BACKGROUND: Schizophrenia and related disorders affect a sizable proportion of any population. Neuroleptic (antipsychotic) medications are the primary treatment for these disorders. Neuroleptic medications are associated with a variety of side effects including tardive dyskinesia. Dyskinesia is a disfiguring movement disorder of the orofacial region that can be tardive (having a slow or belated onset). Tardive dyskinesia (...) is difficult to treat, despite experimentation with several treatments. Calcium channel blockers (diltiazem, nifedipine, nimodipine, verapamil) have been among these experimental treatments. OBJECTIVES: To determine the effects of calcium-channel blocker drugs (diltiazem, nifedipine, nimodipine, verapamil) for treatment of neuroleptic-induced tardive dyskinesia in people with schizophrenia, schizoaffective disorder or other chronic mental illnesses. SEARCH STRATEGY: We updated previous searches in May 2010

Cochrane2011

153. Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women`s health initiative randomized controlled trial

Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women`s health initiative randomized controlled trial 21709199 2011 07 29 2011 08 16 2016 12 15 1527-7755 29 22 2011 Aug 01 Journal of clinical oncology : official journal of the American Society of Clinical Oncology J. Clin. Oncol. Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative (...) randomized controlled trial. 3078-84 10.1200/JCO.2011.34.5967 In light of inverse relationships reported in observational studies of vitamin D intake and serum 25-hydroxyvitamin D levels with risk of nonmelanoma skin cancer (NMSC) and melanoma, we evaluated the effects of vitamin D combined with calcium supplementation on skin cancer in a randomized placebo-controlled trial. Postmenopausal women age 50 to 79 years (N = 36,282) enrolled onto the Women's Health Initiative (WHI) calcium/vitamin D clinical

EvidenceUpdates2011 Full Text: Link to full Text with Trip Pro

154. Calcium carbonate + cholecalciferol (Kalcipos-D®) - Vitamin D and calcium supplement in addition to specific osteoporosis treatment of patients who are at risk of vitamin D and calcium deficiency

Calcium carbonate + cholecalciferol (Kalcipos-D®) - Vitamin D and calcium supplement in addition to specific osteoporosis treatment of patients who are at risk of vitamin D and calcium deficiency Published 08 August 2011 Product Update calcium carbonate equivalent to 500mg calcium, cholecalciferol (vitamin D 3 ) 800 IU (20 microgram) tablets (Kalcipos-D 500mg/800 IU chewable tablets®) (No: 718/11 ) Meda Pharmaceuticals Ltd 08 July 2011 The Scottish Medicines Consortium (SMC) has completed its (...) assessment of the above product and advises NHS Boards and Area Drug and Therapeutic Committees (ADTCs) on its use in NHS Scotland. The advice is summarised as follows: ADVICE: following an abbreviated submission calcium carbonate and cholecalciferol (Kalcipos-D®) is accepted for use within NHS Scotland. Indications under review: ? Prevention and treatment of calcium and vitamin D deficiency in the elderly. ? Vitamin D and calcium supplement in addition to specific osteoporosis treatment of patients who

Scottish Medicines Consortium2011

155. Preliminary evidence suggests remineralizing effects of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP)

Preliminary evidence suggests remineralizing effects of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) Preliminary evidence suggests remineralizing effects of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make a difference with dentistry's premier (...) Council's children's oral health website Evidence Education About * Associated Topics Preliminary evidence suggests remineralizing effects of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Casein phosphopeptide-amorphous calcium phosphate shows promise as an anticariogenic agent. Critical Summary Assessment One long-term RCT and several short-term in vivo and in situ randomized control trials demonstrate the remineralizing

ADA Center for Evidence-Based Dentistry2011

156. Preliminary evidence suggests remineralizing effects of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP)

Preliminary evidence suggests remineralizing effects of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) Preliminary evidence suggests remineralizing effects of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Take advantage of endorsed, discounted business products Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice (...) Council's children's oral health website Evidence Education About * Associated Topics Preliminary evidence suggests remineralizing effects of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Casein phosphopeptide-amorphous calcium phosphate shows promise as an anticariogenic agent. Critical Summary Assessment One long-term RCT and several short-term in vivo and in situ randomized control trials demonstrate the remineralizing

ADA Center for Evidence-Based Dentistry2011

157. Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study.

Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. OBJECTIVE: To investigate associations between long term dietary intake of calcium and risk of fracture of any type, hip fractures, and osteoporosis. DESIGN: A longitudinal and prospective cohort study, based on the Swedish Mammography Cohort, including a subcohort, the Swedish Mammography Cohort Clinical. SETTING: A population based cohort in Sweden established in 1987. PARTICIPANTS: 61,433 (...) type and among them 3871 (6%) a first hip fracture. Of the 5022 women in the subcohort, 1012 (20%) were measured as osteoporotic. The risk patterns with dietary calcium were non-linear. The crude rate of a first fracture of any type was 17.2/1000 person years at risk in the lowest quintile of calcium intake, and 14.0/1000 person years at risk in the third quintile, corresponding to a multivariable adjusted hazard ratio of 1.18 (95% confidence interval 1.12 to 1.25). The hazard ratio for a first hip

BMJ2011 Full Text: Link to full Text with Trip Pro

158. Impact of Coronary Artery Calcium Scanning on Coronary Risk Factors and Downstream Testing The EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) Prospective Randomized Trial

Impact of Coronary Artery Calcium Scanning on Coronary Risk Factors and Downstream Testing The EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) Prospective Randomized Trial 21439754 2011 04 08 2011 06 08 2016 12 15 1558-3597 57 15 2011 Apr 12 Journal of the American College of Cardiology J. Am. Coll. Cardiol. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical (...) Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. 1622-32 10.1016/j.jacc.2011.01.019 We conducted a prospective randomized trial to compare the clinical impact of conventional risk factor modification to that associated with the addition of coronary artery calcium (CAC) scanning. Although CAC scanning predicts cardiac events, its impact on subsequent medical management and coronary artery disease risk is not known. We assigned 2,137 volunteers to groups that either did undergo CAC

EvidenceUpdates2011 Full Text: Link to full Text with Trip Pro

159. Effect of calcium phosphate bone cement augmentation on volar plate fixation of unstable distal radial fractures in the elderly

Effect of calcium phosphate bone cement augmentation on volar plate fixation of unstable distal radial fractures in the elderly 21471414 2011 04 07 2011 06 17 2016 11 25 1535-1386 93 7 2011 Apr 06 The Journal of bone and joint surgery. American volume J Bone Joint Surg Am Effect of calcium phosphate bone cement augmentation on volar plate fixation of unstable distal radial fractures in the elderly. 609-14 10.2106/JBJS.J.00613 Calcium phosphate bone cement increases the stability of implant-bone (...) constructs in patients with an osteoporotic fracture. The purpose of this randomized study was to determine whether augmentation of volar locking plate fixation with calcium phosphate bone cement has any benefit over volar locking plate fixation alone in patients older than sixty-five years of age who have an unstable distal radial fracture. Forty-eight patients (fifty unstable distal radial fractures) were recruited for this study. The mean patient age was seventy-three years. Surgical procedures were

EvidenceUpdates2011

160. Calcium acetate and magnesium carbonate (Osvaren) - treatment of hyperphosphataemia associated with chronic renal insufficiency in patients undergoing dialysis

Calcium acetate and magnesium carbonate (Osvaren) - treatment of hyperphosphataemia associated with chronic renal insufficiency in patients undergoing dialysis

Scottish Medicines Consortium2011